Theratechnologies Inc.
TH.TO
TSX
| Weiss Ratings | TH.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | TH.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | TH.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.90 | |||
| Price History | TH.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -10.45% | |||
| 30-Day Total Return | -9.09% | |||
| 60-Day Total Return | -17.81% | |||
| 90-Day Total Return | 37.93% | |||
| Year to Date Total Return | -9.43% | |||
| 1-Year Total Return | 16.50% | |||
| 2-Year Total Return | -48.28% | |||
| 3-Year Total Return | -80.20% | |||
| 5-Year Total Return | -75.10% | |||
| 52-Week High % Change | -32.59% | |||
| 52-Week Low % Change | 32.70% | |||
| Price | TH.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $3.13 | |||
| 52-Week Low Price | $1.59 | |||
| 52-Week Low Price (Date) | Sep 18, 2024 | |||
| 52-Week High Price (Date) | Jan 07, 2025 | |||
| Valuation | TH.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 67.78M | |||
| Enterprise Value | 101.86M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.17 | |||
| Earnings Per Share Growth | -82.20% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.21 | |||
| Price/Book (Q) | -3.84 | |||
| Enterprise Value/Revenue (TTM) | 1.19 | |||
| Price | $2.40 | |||
| Enterprise Value/EBITDA (TTM) | 9.61 | |||
| Enterprise Value/EBIT | 12.46 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | TH.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 49.36M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | TH.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 514-336-7800 | |||
| Address | 2015 Peel Street Montreal, QC H3A 1T8 | |||
| Website | www.theratech.com | |||
| Country | Canada | |||
| Year Founded | 1993 | |||
| Profitability | TH.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 9.51% | |||
| Profit Margin | -9.67% | |||
| Management Effectiveness | TH.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 7.79% | |||
| Return on Equity | -- | |||
| Income Statement | TH.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 85.87M | |||
| Total Revenue (TTM) | 85.87M | |||
| Revenue Per Share | $1.74 | |||
| Gross Profit (TTM) | 65.42M | |||
| EBITDA (TTM) | 10.60M | |||
| EBIT (TTM) | 8.17M | |||
| Net Income (TTM) | -8.31M | |||
| Net Income Avl. to Common (TTM) | -8.31M | |||
| Total Revenue Growth (Q YOY) | 6.61% | |||
| Earnings Growth (Q YOY) | -186.86% | |||
| EPS Diluted (TTM) | -0.17 | |||
| EPS Diluted Growth (Q YOY) | -90.14% | |||
| Balance Sheet | TH.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 10.79M | |||
| Cash Per Share (Q) | $0.22 | |||
| Total Current Assets (Q) | 43.98M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -25.27M | |||
| Current Ratio (Q) | 1.193 | |||
| Book Value Per Share (Q) | -$0.55 | |||
| Total Assets (Q) | 53.34M | |||
| Total Current Liabilities (Q) | 36.86M | |||
| Total Debt (Q) | 45.61M | |||
| Total Liabilities (Q) | 78.61M | |||
| Total Common Equity (Q) | -25.27M | |||
| Cash Flow | TH.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 942.00K | |||
| Cash from Financing (TTM) | -21.49M | |||
| Net Change in Cash (TTM) | -18.20M | |||
| Levered Free Cash Flow (TTM) | -13.95M | |||
| Cash from Operations (TTM) | 2.38M | |||
